Bank Pan Indonesia Tbk (PNBN)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 750.00 |
|---|---|
| 52-week range | 700.00 – 1,290.00 |
| Return, 1 month / 3 months | −13.3% / −16.7% |
| Return, 1 year / 3 years | −22.6% / −28.8% |
| Trend | Below its 200-day average |
| RSI (14) | 30 |
| Volatility (1 year) | 33.8% |
| Worst drawdown (1 year) | -39.8% |
| Average daily value traded | 2,047.17M IDR |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bank Pan Indonesia, commonly known as Panin Bank, is an Indonesian commercial bank based in Jakarta. It serves individual customers and businesses through branch offices across the country, offering savings and deposit accounts, lending, credit cards and trade-related banking services. Its customers include retail depositors, small and medium-sized enterprises and larger corporate clients, and the bank also provides treasury and payment services. Panin Bank operates as a domestic commercial bank within Indonesia's banking sector.
Bank Pan Indonesia Tbk trades under the code PNBN on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bank Pan Indonesia Tbk (PNBN) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 750.00 on 23 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 421 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 22.6% and over the last three months it fell 16.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.8% | ||
| From 52-week high | -39.8% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.7% | ||
| 6-month return | -24.1% | ||
| 12-month return, skipping the last month | -10.7% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.8% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 2,047.17M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −13.3% |
| 3 months | −16.7% |
| 6 months | −24.1% |
| 1 year | −22.6% |
| 3 years | −28.8% |
| 5 years | +0.6% |
Signals
| 50-day / 200-day average | 857.10 / 923.60 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 23.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Jun 2026 | IDR 42.0000 |
| 8 Jul 2025 | IDR 42.0000 |
| 1 Jul 2022 | IDR 20.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.